6pm Holdings plc - Interim Directors’ Statement

On 13 November, 6pm Holdings plc published its Interim Directors’ Statement in which it revealed that the Group has registered 12 consecutive months of profits without hampering any investment being made as part of the strategy being implemented. As a result, the Directors are undertaking that if the company continues to achieve its operational performance targets, a dividend will be proposed for approval at the forthcoming Annual General Meeting.

The announcement also explained that as part of the Group’s strategy to move from a service to a product-based company, it targeted clinical solutions used within the NHS Market in the UK with the aim of delivering additional value. The first such clinical solutions, named Care Solutions Climate HIV, was rolled out in the beginning of November in collaboration with the North Middlesex University Hospital. A number of other Trusts have already shown interest in acquiring a licence for this solution. Another clinical solution relates to the monitoring and treatment of stroke patients with live deployment expected by the end of the year. At the beginning of 2013, this solution will be available for site referencing with other Trusts also showing serious interest.

In the meantime, the 6pm Group launched its Quick products suite in line with its strategy of ‘low margin, high volume business’. 6pm reported notable interest, both locally and internationally, in the first two products launched under this suite which is also creating the opportunity for the provision of training services. Additional products under the Quick suite are expected to be launched and marketed in the first half of 2013.

In conclusion, the Directors noted that the 2013 business plan is currently being drawn up and will be based on four core business objectives, namely: profitability, stability, growth and business model. As such, new opportunities will be evaluated in line with these business objectives, in order to gain the best shareholders’ value.